170 related articles for article (PubMed ID: 29156588)
21. From poly(alkyl cyanoacrylate) to squalene as core material for the design of nanomedicines.
Mura S; Fattal E; Nicolas J
J Drug Target; 2019; 27(5-6):470-501. PubMed ID: 30720372
[TBL] [Abstract][Full Text] [Related]
22. Cytotoxicity of Nanomaterials: Using Nanotoxicology to Address the Safety Concerns of Nanoparticles.
Saifi MA; Khan W; Godugu C
Pharm Nanotechnol; 2018; 6(1):3-16. PubMed ID: 29065848
[TBL] [Abstract][Full Text] [Related]
23. In vitro and in vivo evaluation of Δ⁹-tetrahidrocannabinol/PLGA nanoparticles for cancer chemotherapy.
Martín-Banderas L; Muñoz-Rubio I; Prados J; Álvarez-Fuentes J; Calderón-Montaño JM; López-Lázaro M; Arias JL; Leiva MC; Holgado MA; Fernández-Arévalo M
Int J Pharm; 2015 Jun; 487(1-2):205-12. PubMed ID: 25899283
[TBL] [Abstract][Full Text] [Related]
24. Enhanced biocompatibility and wound healing properties of biodegradable polymer-modified allyl 2-cyanoacrylate tissue adhesive.
Lee YJ; Son HS; Jung GB; Kim JH; Choi S; Lee GJ; Park HK
Mater Sci Eng C Mater Biol Appl; 2015 Jun; 51():43-50. PubMed ID: 25842106
[TBL] [Abstract][Full Text] [Related]
25. Cytotoxity of nanoparticles is influenced by size, proliferation and embryonic origin of the cells used for testing.
Fröhlich E; Meindl C; Roblegg E; Griesbacher A; Pieber TR
Nanotoxicology; 2012 Jun; 6(4):424-39. PubMed ID: 21627401
[TBL] [Abstract][Full Text] [Related]
26. In vitro toxicity of Stearoyl-poly(glycerol adipate) nanoparticles.
Weiss VM; Naolou T; Groth T; Kressler J; Mäder K
J Appl Biomater Funct Mater; 2012; 10(3):163-9. PubMed ID: 23242880
[TBL] [Abstract][Full Text] [Related]
27. Tumor accumulation of NIR fluorescent PEG-PLA nanoparticles: impact of particle size and human xenograft tumor model.
Schädlich A; Caysa H; Mueller T; Tenambergen F; Rose C; Göpferich A; Kuntsche J; Mäder K
ACS Nano; 2011 Nov; 5(11):8710-20. PubMed ID: 21970766
[TBL] [Abstract][Full Text] [Related]
28. RETRACTED: Enhanced antitumor efficacy of 5-fluorouracil loaded methoxy poly(ethylene glycol)-poly(lactide) nanoparticles for efficient therapy against breast cancer.
Yuan Z; Qu X; Wang Y; Zhang DY; Luo JC; Jia N; Zhang ZT
Colloids Surf B Biointerfaces; 2015 Apr; 128():489-497. PubMed ID: 25779606
[TBL] [Abstract][Full Text] [Related]
29. Investigation of polymer and nanoparticle properties with nicotinic acid and p-aminobenzoic acid grafted on poly(ε-caprolactone)-poly(ethylene glycol)-poly(ε-caprolactone) via click chemistry.
Suksiriworapong J; Sripha K; Kreuter J; Junyaprasert VB
Bioconjug Chem; 2011 Apr; 22(4):582-94. PubMed ID: 21375231
[TBL] [Abstract][Full Text] [Related]
30. Size-dependent cytotoxicity of amorphous silica nanoparticles in human hepatoma HepG2 cells.
Li Y; Sun L; Jin M; Du Z; Liu X; Guo C; Li Y; Huang P; Sun Z
Toxicol In Vitro; 2011 Oct; 25(7):1343-52. PubMed ID: 21575712
[TBL] [Abstract][Full Text] [Related]
31. Synthesis of poly(alkyl cyanoacrylate)-based colloidal nanomedicines.
Nicolas J; Couvreur P
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2009; 1(1):111-127. PubMed ID: 20049783
[TBL] [Abstract][Full Text] [Related]
32. Box-Behnken optimization design and enhanced oral bioavailability of thymopentin-loaded poly (butyl cyanoacrylate) nanoparticles.
Jin X; Huang A; Ping Q; Cao F; Su Z
Pharmazie; 2011 May; 66(5):339-47. PubMed ID: 21699067
[TBL] [Abstract][Full Text] [Related]
33. [Influence of particle size and MePEG molecular weight on in vitro macrophage uptake and in vivo long circulating of stealth nanoparticles in rats].
Fang C; Shi B; Hong MH; Pei YY; Chen HZ
Yao Xue Xue Bao; 2006 Apr; 41(4):305-12. PubMed ID: 16856473
[TBL] [Abstract][Full Text] [Related]
34. Cytotoxicity and cellular uptake of newly synthesized fucoidan-coated nanoparticles.
Lira MC; Santos-Magalhães NS; Nicolas V; Marsaud V; Silva MP; Ponchel G; Vauthier C
Eur J Pharm Biopharm; 2011 Sep; 79(1):162-70. PubMed ID: 21349331
[TBL] [Abstract][Full Text] [Related]
35. A Protocol for the Production of Gliadin-cyanoacrylate Nanoparticles for Hydrophilic Coating.
Kim S
J Vis Exp; 2016 Jul; (113):. PubMed ID: 27500790
[TBL] [Abstract][Full Text] [Related]
36. In vitro toxicity of iron oxide nanoparticle: oxidative damages on Hep G2 cells.
Sadeghi L; Tanwir F; Yousefi Babadi V
Exp Toxicol Pathol; 2015 Feb; 67(2):197-203. PubMed ID: 25497787
[TBL] [Abstract][Full Text] [Related]
37. Comparison of different cytotoxicity assays for in vitro evaluation of mesoporous silica nanoparticles.
Braun K; Stürzel CM; Biskupek J; Kaiser U; Kirchhoff F; Lindén M
Toxicol In Vitro; 2018 Oct; 52():214-221. PubMed ID: 29940343
[TBL] [Abstract][Full Text] [Related]
38. Preparation, in vitro and in vivo evaluation of polymeric nanoparticles based on hyaluronic acid-poly(butyl cyanoacrylate) and D-alpha-tocopheryl polyethylene glycol 1000 succinate for tumor-targeted delivery of morin hydrate.
Abbad S; Wang C; Waddad AY; Lv H; Zhou J
Int J Nanomedicine; 2015; 10():305-20. PubMed ID: 25609946
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of polylactic acid nanoparticles safety using Drosophila model.
Legaz S; Exposito JY; Lethias C; Viginier B; Terzian C; Verrier B
Nanotoxicology; 2016 Oct; 10(8):1136-43. PubMed ID: 27108761
[TBL] [Abstract][Full Text] [Related]
40. Selegiline-functionalized, PEGylated poly(alkyl cyanoacrylate) nanoparticles: Investigation of interaction with amyloid-β peptide and surface reorganization.
Le Droumaguet B; Souguir H; Brambilla D; Verpillot R; Nicolas J; Taverna M; Couvreur P; Andrieux K
Int J Pharm; 2011 Sep; 416(2):453-60. PubMed ID: 21251960
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
